Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T2000 in Myoclonus Dystonia
NCT00506012Phase 2Terminated
- Start
- Aug 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of T-2000 in myoclonus dystonia (DYT11). Started Aug 2007; status: terminated.
02
Drugs
T-2000
03
Conditions
myoclonus dystonia (DYT11)
Beyond the preview
Go deeper on NCT00506012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506012.